Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 75, Issue , 2013, Pages 7-17

  Tung, Chun Liang ^a,b   Lin, Szu Ting ^c   Chou, Hsiu Chuan ^c   Chen, Yi Wen ^c   Lin, Hwan Chung ^a   Tung, Chung Liang ^a   Huang, Kao Jean ^d   Chen, Yi Ju ^a   Lee, Ying Ray ^a,e   Chan, Hong Lin ^c  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^e Min Hwei College of Health Care Management   (Taiwan)

Author keywords

2D DIGE; Biomarker; Oral squamous cell carcinoma; Plasma; Proteomic

Indexed keywords

APOLIPOPROTEIN A1; BIOLOGICAL MARKER; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; FIBRINOGEN GAMMA CHAIN; GLYCOPROTEIN; HAPTOGLOBIN; LEUCINE RICH ALPHA 2 GLYCOPROTEIN; PLASMA PROTEIN; S6 KINASE; S6 KINASE ALPHA 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BETEL NUT; BLOOD SAMPLING; CANCER GROWTH; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; GENE PRODUCT; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL HISTORY; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ADULT; ARECA; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUTS; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTANCE-RELATED DISORDERS; TAIWAN; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VITAMIN D-BINDING PROTEIN;

EID: 84871745003     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.11.017     Document Type: Article

References (27)

1. Lin Y.S., Jen Y.M., Wang B.B., Lee J.C., Kang B.H. Epidemiology of oral cavity cancer in Taiwan with emphasis on the role of betel nut chewing. ORL J. Otorhinolaryngol. Relat Spec. 2005, 67:230-236.
2. Carpenter J.M., Syms M.J., Sniezek J.C. Oral carcinoma associated with betel nut chewing in the pacific: an impending crisis?. Pac. Health Dialog. 2005, 12:158-162.
3. Lee H.C., Yin P.H., Yu T.N., Chang Y.D., Hsu W.C., Kao S.Y., Chi C.W., Liu T.Y., Wei Y.H. Accumulation of mitochondrial DNA deletions in human oral tissues - effects of betel quid chewing and oral cancer. Mutat. Res. 2001, 493:67-74.
4. Chen P.H., Shieh T.Y., Ho P.S., Tsai C.C., Yang Y.H., Lin Y.C., Ko M.S., Tsai P.C., Chiang S.L., Tu H.P., Ko Y.C. Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan. BMC Cancer 2007, 7:101.
5. Lin S.T., Chou H.C., Chang S.J., Chen Y.W., Lyu P.C., Wang W.C., Chang M.D., Chan H.L. Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. J. Proteomics 2012, 75:5822-5847.
6. Wu C.L., Chou H.C., Cheng C.S., Li J.M., Lin S.T., Chen Y.W., Chan H.L. Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J. Proteomics 2012, 75:1991-2014.
7. Lai C.H., Chang N.W., Lin C.F., Lin C.D., Lin Y.J., Wan L., Sheu J.J., Chen S.Y., Huang Y.P., Sing Y.T., Tao T.W., Lai C.K., Tsai M.H., Chan H.L., Jou Y.J., Lin C.W. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma. Clin. Chim. Acta 2010, 411:984-991.
8. Jou Y.J., Lin C.D., Lai C.H., Chen C.H., Kao J.Y., Chen S.Y., Tsai M.H., Huang S.H., Lin C.W. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal. Chim. Acta 2010, 681:41-48.
9. Chen Y.W., Liu J.Y., Lin S.T., Li J.M., Huang S.H., Chen J.Y., Wu J.Y., Kuo C.C., Wu C.L., Lu Y.C., Chen Y.H., Fan C.Y., Huang P.C., Law C.H., Lyu P.C., Chou H.C., Chan H.L. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. Mol. Biosyst. 2011, 7:3065-3074.
10. Lai T.C., Chou H.C., Chen Y.W., Lee T.R., Chan H.T., Shen H.H., Lee W.T., Lin S.T., Lu Y.C., Wu C.L., Chan H.L. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J. Proteome. Res. 2010, 9:1302-1322.
11. Hung P.H., Chen Y.W., Cheng K.C., Chou H.C., Lyu P.C., Lu Y.C., Lee Y.R., Wu C.T., Chan H.L. Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis. Mol. Biosyst. 2011, 7:1990-1998.
12. Rader D.J. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 2003, 92:42J-49J.
13. Chong P.K., Lee H., Zhou J., Liu S.C., Loh M.C., So J.B., Lim K.H., Yeoh K.G., Lim Y.P. Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model. J. Proteomics 2010, 73:1632-1640.
14. Takeuchi H., Ikeuchi S., Kitagawa Y., Shimada A., Oishi T., Isobe Y., Kubochi K., Kitajima M., Matsumoto S. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J. Gastroenterol. Hepatol. 2007, 22:2222-2227.
15. Andersen J.D., Boylan K.L., Jemmerson R., Geller M.A., Misemer B., Harrington K.M., Weivoda S., Witthuhn B.A., Argenta P., Vogel R.I., Skubitz A.P. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J. Ovarian. Res. 2010, 3:21.
16. Kang S., Chen J. Targeting RSK2 in human malignancies. Expert. Opin. Ther. Targets 2011, 15:11-20.
17. Chiu C.C., Chen B.H., Hour T.C., Chiang W.F., Wu Y.J., Chen C.Y., Chen H.R., Chan P.T., Liu S.Y., Chen J.Y. Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signaling cascade involving SFKs and ERK1/2. Biochem. Biophys. Res. Commun. 2010, 399:60-65.
18. Chen J.Y., Hung C.C., Huang K.L., Chen Y.T., Liu S.Y., Chiang W.F., Chen H.R., Yen C.Y., Wu Y.J., Ko J.Y., Jou Y.S. Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. Neoplasia 2008, 10:1393-1401.
19. Kang S., Dong S., Guo A., Ruan H., Lonial S., Khoury H.J., Gu T.L., Chen J. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529. J. Biol. Chem. 2008, 283:4652-4657.
20. Elf S., Blevins D., Jin L., Chung T.W., Williams I.R., Lee B.H., Lin J.X., Leonard W.J., Taunton J., Khoury H.J., Kang S. p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia. Blood 2011, 117:6885-6894.
21. Clark D.E., Errington T.M., Smith J.A., Frierson H.F., Weber M.J., Lannigan D.A. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res. 2005, 65:3108-3116.
22. Bijian K., Mlynarek A.M., Balys R.L., Jie S., Xu Y., Hier M.P., Black M.J., Di Falco M.R., LaBoissiere S., Alaoui-Jamali M.A. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J. Proteome Res. 2009, 8:2173-2185.
23. Bijian K., Mlynarek A.M., Balys R.L., Jie S., Xu Y., Hier M.P., Black M.J., Di Falco M.R., LaBoissiere S., Alaoui-Jamali M.A. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J. Proteome Res. 2009, 8:2173-2185.
24. Chan H.L., Gharbi S., Gaffney P.R., Cramer R., Waterfield M.D., Timms J.F. Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 2005, 5:2908-2926.
25. Dalpathado D.S., Desaire H. Glycopeptide analysis by mass spectrometry. Analyst 2008, 133:731-738.
26. Rabilloud T., Heller M., Gasnier F., Luche S., Rey C., Aebersold R., Benahmed M., Louisot P., Lunardi J. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002, 277:19396-19401.
27. Wagner E., Luche S., Penna L., Chevallet M., van Dorsselaer A., Leize-Wagner E., Rabilloud T. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 2002, 366:777-785.